SANUWAVE Health, Inc.
SNWV
$33.98
$0.020.04%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 40.89% | 57.43% | 61.50% | 59.99% | 55.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 40.89% | 57.43% | 61.50% | 59.99% | 55.01% |
| Cost of Revenue | 12.78% | 23.53% | 33.05% | 33.95% | 57.09% |
| Gross Profit | 51.37% | 70.89% | 72.77% | 70.94% | 54.25% |
| SG&A Expenses | 48.50% | 44.36% | 31.14% | 30.21% | 2.40% |
| Depreciation & Amortization | 6.87% | 7.45% | 7.25% | 4.92% | 0.40% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.73% | 35.87% | 30.51% | 30.00% | 15.60% |
| Operating Income | 74.17% | 406.07% | 1,815.94% | 1,105.01% | 229.37% |
| Income Before Tax | -1,722.60% | -1,008.49% | -88.35% | -21.48% | 99.23% |
| Income Tax Expenses | 575.00% | 575.00% | 575.00% | 575.00% | 100.00% |
| Earnings from Continuing Operations | -1,710.80% | -1,007.98% | -88.47% | -21.56% | 99.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,710.80% | -1,007.98% | -88.47% | -21.56% | 99.22% |
| EBIT | 74.17% | 406.07% | 1,815.94% | 1,105.01% | 229.37% |
| EBITDA | 66.14% | 252.80% | 557.26% | 1,207.98% | 338.79% |
| EPS Basic | -493.62% | -162.56% | 34.24% | 56.79% | 100.80% |
| Normalized Basic EPS | 36.98% | -76.89% | 15.82% | 46.36% | 94.66% |
| EPS Diluted | -1,607.89% | -143.05% | 31.08% | 54.94% | 99.63% |
| Normalized Diluted EPS | 33.55% | -74.96% | 15.23% | 46.02% | 94.44% |
| Average Basic Shares Outstanding | 174.15% | 146.81% | 132.25% | 110.85% | 77.95% |
| Average Diluted Shares Outstanding | 171.66% | 140.71% | 137.70% | 117.31% | 85.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |